Skip to main content
. Author manuscript; available in PMC: 2022 Mar 15.
Published in final edited form as: Cancer Res. 2021 Jul 9;81(18):4835–4848. doi: 10.1158/0008-5472.CAN-20-2811

Table.

Patient characteristics

Characteristic Pt-1 Pt-2 Pt-3 Pt-4
Histology Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma
EGFR Mutations EGFR exon19del EGFR exon19del EGFR L858R+T790M EGFR L858R+T790M
Sex M F F F
Age 76 42 80 57 (43 at diagnosis)
Smoking 20 pack-years 5 pack-years Never Never
Treatments TKI failure (Osimertinib failure) TKI failure (Afatinib failure) TKI failure (Gefitinib failure) TKI failure (Osimertinib failure)
Sample types Liver biopsy Pleural effusion Bronsoscopy biopsy Bronchoscopy biopsy
Raw reads 354,246,362 312,086,257 243,573,120 444,150,695
total cells after cut-off 3763 2651 747 936
included tumor cells 3697 118 237 166